{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Bionomics Limited"},"Symbol":{"label":"Symbol","value":"BNOX"},"Address":{"label":"Address","value":"200 GREENHILL ROAD, EASTWOOD, 5063, Australia"},"Phone":{"label":"Phone","value":"+61 881507400"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Bionomics Ltd is a global, clinical-stage biopharmaceutical company. It is primarily engaged in the development of therapeutics for diseases of the central nervous system and cancer. The company's reportable segment is the Drug Discovery and Development segment which is engaged in the discovery, development, and commercialization of compounds to match a target product profile. The company generates all of its revenues from Australia."},"CompanyUrl":{"label":"Company Url","value":"https://www.bionomics.com.au"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Julie Kerner","title":"Senior Vice President-Business Operations"},{"name":"Liz Doolin","title":"Senior Vice President-Clinical Development"},{"name":"Mark A. Smith","title":"Chief Medical Officer"},{"name":"Spyridon Papapetropoulos","title":"President, Chief Executive Officer & Director"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}